Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad

다국어 초록 (Multilingual Abstract)

Myeloid-derived suppressor cells (MDSCs) have strong immunosuppressive activity and are morphologically similar to conventional monocytes and granulocytes. The development and classification of these cells have, however, been controversial. The activation network of MDSCs is relatively complex, and their mechanism of action is poorly understood, creating an avenue for further research. In recent years, MDSCs have been found to play an important role in immune regulation and in effectively inhibiting the activity of effector lymphocytes. Under certain conditions, particularly in the case of tissue damage or inflammation, MDSCs play a leading role in the immune response of the central nervous system. In cancer, however, this can lead to tumor immune evasion and the development of related diseases. Under cancerous conditions, tumors often alter bone marrow formation, thus affecting progenitor cell differentiation, and ultimately, MDSC accumulation. MDSCs are important contributors to tumor progression and play a key role in promoting tumor growth and metastasis, and even reduce the efficacy of immunotherapy. Currently, a number of studies have demonstrated that MDSCs play a key regulatory role in many clinical diseases. In light of these studies, this review discusses the origin of MDSCs, the mechanisms underlying their activation, their role in a variety of clinical diseases, and their function in immune response regulation.

참고문헌 (Reference)

• 1 Kumar S, "ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer" 128 : 5095-5109, 2018
• 2 Hoffmann SHL, "Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer" 9 : 5869-5885, 2019
• 3 Xie Z, "Valproic acid attenuates immunosuppressive function of myeloidderived suppressor cells" 137 : 359-365, 2018
• 4 Krishna U, "Uveitis : a sight-threatening disease which can impact all systems" 93 : 766-773, 2017
• 5 Marigo I, "Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor" 32 : 790-802, 2010
• 6 Li YD, "Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer" 68 : 1501-1513, 2019
• 7 Kim J, "Tumor-associated macrophages and neutrophils in tumor microenvironment" 2016 : 6058147-, 2016
• 8 Pappalardo JL, "Transcriptomic and clonal characterization of T cells in the human central nervous system" 5 : eabb8786-, 2020
• 9 Condamine T, "Transcriptional regulation of myeloid-derived suppressor cells" 98 : 913-922, 2015
• 10 Mandruzzato S, "Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry : results from an interim study" 65 : 161-169, 2016
• 11 Limagne E, "Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients" 8 : e1564505-, 2019
• 12 Moliné-Velázquez V, "The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability" 67 : 149-164, 2014
• 13 Kawano M, "The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer" 5 : 18217-, 2015
• 14 Salminen A, "The role of myeloid-derived suppressor cells(MDSC)in the inflammaging process" 48 : 1-10, 2018
• 15 Gunes EG, "The role of myeloid-derived suppressor cells in hematologic malignancies" 32 : 518-526, 2020
• 16 Melero-Jerez C, "The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis" 140 : 104869-, 2020
• 17 Melero-Jerez C, "The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis" 127 : 13-31, 2019
• 18 Kumar V, "The nature of myeloid-derived suppressor cells in the tumor microenvironment" 37 : 208-220, 2016
• 19 Lin Q, "The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway" 10 : 693-, 2019
• 20 Milette S, "The innate immune architecture of lung tumors and its implication in disease progression" 247 : 589-605, 2019
• 21 Borisov KE, "The immunosuppressive microenvironment of malignant gliomas" 77 : 54-63, 2015
• 22 Duechler M, "The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes" 219 : 158-165, 2014
• 23 Mi Y, "The emerging role of myeloid-derived suppressor cells in the glioma immune suppressive microenvironment" 11 : 737-, 2020
• 24 Lee JW, "The combination of MEK inhibitor with immunomodulatory antibodies targeting programmed death 1 and programmed death ligand 1 results in prolonged survival in Kras/p53-driven lung cancer" 14 : 1046-1060, 2019
• 25 Luker AJ, "The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer" 21 : 8-, 2020
• 26 Mengos AE, "The CD14+HLA-DRlo/neg monocyte : an immunosuppressive phenotype that restrains responses to cancer immunotherapy" 10 : 1147-, 2019
• 27 Liu Z, "TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages" 469 : 173-185, 2020
• 28 Li S, "TET2 promotes antitumor immunity by governing G-MDSCs and CD8+T-cell numbers" 21 : e49425-, 2020
• 29 Shou D, "Suppressive role of myeloid-derived suppressor cells(MDSCs)in the microenvironment of breast cancer and targeted immunotherapies" 7 : 64505-64511, 2016
• 30 Satoh Y, "Supplementation of l-arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy" 111 : 2248-2258, 2020
• 31 Llitjos JF, "Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4" 239 : 473-483, 2016
• 32 Rébé C, "STAT3 activation : a key factor in tumor immunoescape" 2 : e23010-, 2013
• 33 Wang Z, "Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187" 9 : 36-, 2020
• 34 Bronte V, "Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards" 7 : 12150-, 2016
• 35 Shukla VC, "Reciprocal signaling between myeloid derived suppressor and tumor cells enhances cellular motility and is mediated by structural cues in the microenvironment" 4 : e2000049-, 2020
• 36 Yang P, "Prevalence and clinical features of systemic diseases in Chinese patients with uveitis" 105 : 75-82, 2021
• 37 Tada K, "Pretreatment immune status correlates with progression-free survival in chemotherapy-treated metastatic colorectal cancer patients" 4 : 592-599, 2016
• 38 Vidyarthi A, "Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity" 68 : 1995-2004, 2019
• 39 Tcyganov E, "Plasticity of myeloid-derived suppressor cells in cancer" 51 : 76-82, 2018
• 40 Salminen A, "Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells(MDSC) : Impact on cancer and age-related chronic inflammatory disorders" 61 : 231-240, 2018
• 41 Iacobaeus E, "Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis" 96 : 820-830, 2018
• 42 Long X, "Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity" 4 : 2319-2330, 2019
• 43 Sica A, "Origin and functions of tumor-associated myeloid cells(TAMCs)" 5 : 133-149, 2012
• 44 Poschke I, "On the armament and appearances of human myeloid-derived suppressor cells" 144 : 250-268, 2012
• 45 Coffelt SB, "Neutrophils in cancer : neutral no more" 16 : 431-446, 2016
• 46 Treffers LW, "Neutrophils in cancer" 273 : 312-328, 2016
• 47 Aarts CEM, "Neutrophils as myeloid-derived suppressor cells" 48 (48): e12989-, 2018
• 48 Dumitru CA, "Neutrophils and granulocytic myeloid-derived suppressor cells : immunophenotyping, cell biology and clinical relevance in human oncology" 61 : 1155-1167, 2012
• 49 González H, "Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases" 274 : 1-13, 2014
• 50 Leiber A, "Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli" 47 : 1009-1021, 2017
• 51 Feng PH, "NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells" 69 : 2147-2155, 2020
• 52 Yang Z, "Myeloid-derived suppressor cells-new and exciting players in lung cancer" 13 : 10-, 2020
• 53 Ma X, "Myeloid-derived suppressor cells promote metastasis in breast cancer after the stress of operative removal of the primary cancer" 9 : 855-, 2019
• 54 Wegner A, "Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease" 151 : 26-42, 2017
• 55 Jeong HJ, "Myeloid-derived suppressor cells mediate inflammation resolution in humans and mice with autoimmune uveoretinitis" 200 : 1306-1315, 2018
• 56 Moliné-Velázquez V, "Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis" 21 : 678-691, 2011
• 57 Hosomi S, "Myeloid-derived suppressor cells infiltrate the brain and suppress neuroinflammation in a mouse model of focal traumatic brain injury" 406 : 457-466, 2019
• 58 Hanson EM, "Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells" 183 : 937-944, 2009
• 59 Knier B, "Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity" 19 : 1341-1351, 2018
• 60 Veglia F, "Myeloid-derived suppressor cells coming of age" 19 : 108-119, 2018
• 61 Gabrilovich DI, "Myeloid-derived suppressor cells as regulators of the immune system" 9 : 162-174, 2009
• 62 Law AMK, "Myeloid-derived suppressor cells as a therapeutic target for cancer" 9 : 9-, 2020
• 63 Safarzadeh E, "Myeloid-derived suppressor cells : important contributors to tumor progression and metastasis" 233 : 3024-3036, 2018
• 64 Tu Z, "Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis" 53 : 959-966, 2012
• 65 Nakamura K, "Myeloid immunosuppression and immune checkpoints in the tumor microenvironment" 17 : 1-12, 2020
• 66 Ostrand-Rosenberg S, "Myeloid derived-suppressor cells : their role in cancer and obesity" 51 : 68-75, 2018
• 67 Melero-Jerez C, "Myeloid derived suppressor cells in inflammatory conditions of the central nervous system" 1862 : 368-380, 2016
• 68 Brajer-Luftmann B, "Molecules of damage-associated patterns in bronchoalveolar lavage fluid and serum in chronic obstructive pulmonary disease" 1113 : 27-35, 2019
• 69 Condamine T, "Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function" 32 : 19-25, 2011
• 70 Cantoni C, "Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis" 133 : 61-77, 2017
• 71 Arcuri C, "Microglia-glioma cross-talk: a two way approach to new strategies against glioma" 22 : 268-309, 2017
• 72 Xu Z, "MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma" 284 : 2410-2424, 2017
• 73 Chang CH, "Metabolic competition in the tumor microenvironment is a driver of cancer progression" 162 : 1229-1241, 2015
• 74 Lee HJ, "Mesenchymal stem/stromal cells protect against autoimmunity via CCL2-dependent recruitment of myeloid-derived suppressor cells" 194 : 3634-3645, 2015
• 75 Chalmin F, "Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells" 120 : 457-471, 2010
• 76 Wurdinger T, "Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells : how to break a vicious cycle" 1846 : 560-575, 2014
• 77 Conway EM, "Macrophages, inflammation, and lung cancer" 193 : 116-130, 2016
• 78 Koh J, "MDSC subtypes and CD39 expression on CD8+T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC" 50 : 1810-1819, 2020
• 79 Bird L, "MDSC metabolite stuns T cells" 20 : 352-353, 2020
• 80 Gao Y, "Lnc-C/EBPβ negatively regulates the suppressive function of myeloid-derived suppressor cells" 6 : 1352-1363, 2018
• 81 Condamine T, "Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients" 1 : aaf8943-, 2016
• 82 Chai E, "LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression" 11 : 7307-7315, 2019
• 83 Brand A, "LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells" 24 : 657-671, 2016
• 84 Mohrherr J, "JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression" 145 : 3376-3388, 2019
• 85 Jin P, "Interferon-γand tumor necrosis factor-α polarize bone marrow stromal cells uniformly to a Th1 phenotype" 6 : 26345-, 2016
• 86 Haghayegh Jahromi N, "Intercellular adhesion molecule-1(ICAM-1)and ICAM-2 differentially contribute to peripheral activation and CNS entry of autoaggressive Th1 and Th17 cells in experimental autoimmune encephalomyelitis" 10 : 305-, 2020
• 87 Alabanza LM, "Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells" 191 : 3764-3777, 2013
• 88 Ye TH, "Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis" 8 : e2534-, 2017
• 89 Tian T, "Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer" 15 : 425-432, 2015
• 90 Huang A, "Increased CD14(+)HLA-DR(-/low)myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients" 62 : 1439-1451, 2013
• 91 Gielen PR, "Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue" 74 : 390-400, 2015
• 92 Singh A, "In vitro generation of human neutrophilic myeloid-derived suppressor cells" 2236 : 77-83, 2021
• 93 Adah D, "Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics" 110 : 25-34, 2016
• 94 Groth C, "Immunosuppression mediated by myeloid-derived suppressor cells(MDSCs)during tumour progression" 120 : 16-25, 2019
• 95 Bruderek K, "Immunophenotyping of circulating myeloid-derived suppressor cells(MDSC)in the peripheral blood of cancer patients" 2236 : 1-7, 2021
• 96 Özkan B, "Immunomodulatory function of myeloid-derived suppressor cells during B cellmediated immune responses" 19 : 1468-, 2018
• 97 de Goeje PL, "Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer" 4 : e1014242-, 2015
• 98 Gieryng A, "Immune microenvironment of gliomas" 97 : 498-518, 2017
• 99 Ranjan A, "Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth" 8 : 47632-47641, 2017
• 100 Kamran N, "Immature myeloid cells in the tumor microenvironment : implications for immunotherapy" 189 : 34-42, 2018
• 101 Gatti-Mays ME, "If we build it they will come : targeting the immune response to breast cancer" 5 : 37-, 2019
• 102 Wang J, "Identification of CD4+CD25+CD127-regulatory T cells and CD14+HLADR-/low myeloidderived suppressor cells and their roles in the prognosis of breast cancer" 5 : 208-212, 2016
• 103 Weber R, "IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy" 359 : 104254-, 2021
• 104 Elliott LA, "Human tumor-infiltrating myeloid cells : phenotypic and functional diversity" 8 : 86-, 2017
• 105 Tavukçuoğlu E, "Human splenic polymorphonuclear myeloid-derived suppressor cells(PMN-MDSC)are strategically located immune regulatory cells in cancer" 50 : 2067-2074, 2020
• 106 Bruger AM, "How to measure the immunosuppressive activity of MDSC : assays, problems and potential solutions" 68 : 631-644, 2019
• 107 Thakuri BKC, "HCV-associated exosomes upregulate RUNXOR and RUNX1 expressions to promote MDSC expansion and suppressive functions through STAT3-miR124 axis" 9 : 2715-, 2020
• 108 Zhang Q, "Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma" 11 : 1248-1267, 2021
• 109 Wang Y, "Granulocytic myeloid-derived suppressor cells promote the stemness of colorectal cancer cells through exosomal S100A9" 6 : 1901278-, 2019
• 110 Passaro A, "Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy" 22 : 603-611, 2020
• 111 Alban TJ, "Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis" 3 : e122264-, 2018
• 112 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 68 : 394-424, 2018
• 113 Koehn BH, "GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells" 126 : 1621-1628, 2015
• 114 Kohanbash G, "GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α" 73 : 6413-6423, 2013
• 115 Glenn JD, "Frontline Science : Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung" 105 : 829-841, 2019
• 116 Chaib M, "Friend or foe? Recent strategies to target myeloid cells in cancer" 8 : 351-, 2020
• 117 Ibrahim ML, "Expression profiles and function of IL6in polymorphonuclear myeloid-derived suppressor cells" 69 : 2233-2245, 2020
• 118 Bobetsis YA, "Exploring the relationship between periodontal disease and pregnancy complications" 137 (137): 7S-13S, 2006
• 119 Gielen PR, "Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function" 18 : 1253-1264, 2016
• 120 Cassetta L, "Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation" 8 : e001223-, 2020
• 121 Aarts CEM, "Different MDSC activity of G-CSF/dexamethasone mobilized neutrophils: benefits to the patient?" 10 : 1110-, 2020
• 122 Cassetta L, "Deciphering myeloid-derived suppressor cells : isolation and markers in humans, mice and nonhuman primates" 68 : 687-697, 2019
• 123 Koehn BH, "Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD" 134 : 1670-1682, 2019
• 124 Ioannou M, "Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease" 188 : 1136-1146, 2012
• 125 Dai H, "Connections between metabolism and epigenetic modification in MDSCs" 21 : 7356-, 2020
• 126 Safarzadeh E, "Circulating myeloid-derived suppressor cells : an independent prognostic factor in patients with breast cancer" 234 : 3515-3525, 2019
• 127 Mastorodemos V, "Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis : therapeutic implications" 22 : 181-195, 2015
• 128 Elliott DM, "Cannabidiol attenuates experimental autoimmune encephalomyelitis model of multiple sclerosis through induction of myeloid-derived suppressor cells" 9 : 1782-, 2018
• 129 Siegel RL, "Cancer statistics, 2018" 68 : 7-30, 2018
• 130 Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012" 136 : E359-E386, 2015
• 131 Hori M, "Cancer incidence and incidence rates in Japan in 2009 : a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan(MCIJ)project" 45 : 884-891, 2015
• 132 Hsu YL, "CXCL17-derived CD11b+Gr-1+myeloidderived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB" 21 : 23-, 2019
• 133 Gaetani L, "CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases : implications for treatment" 41 : 1023-1037, 2020
• 134 Li J, "CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer" 6 : e1320011-, 2017
• 135 Karakasheva TA, "CD38+M-MDSC expansion characterizes a subset of advanced colorectal cancer patients" 3 : e97022-, 2018
• 136 Parney IF, "Basic concepts in glioma immunology" 746 : 42-52, 2012
• 137 Heuvers ME, "Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients" 81 : 468-474, 2013
• 138 Shi H, "Arctigenin ameliorates inflammation by regulating accumulation and functional activity of MDSCs in endotoxin shock" 41 : 2090-2100, 2018
• 139 Kerr EC, "Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations" 31 : 354-361, 2008
• 140 Mei Y, "Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q)MDS" 32 : 1023-1033, 2018
• 141 Li W, "Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triplenegative breast cancer" 28 : 87-103, 2018
• 142 Pinton L, "Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression" 7 : 1168-1184, 2016
• 143 Sun R, "A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma : implications for the roles of MDSC and Th17 cells in lymphoma progression" 15 : 246-261, 2021
• 144 Tavakkoli M, "A novel paradigm between leukocytosis, G-CSF secretion, neutrophil-to-lymphocyte ratio, myeloid-derived suppressor cells, and prognosis in non-small cell lung cancer" 9 : 295-, 2019
• 145 Mochizuki M, "A new era of uveitis : impact of polymerase chain reaction in intraocular inflammatory diseases" 61 : 1-20, 2017
• 146 Oh K, "A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 transsignaling in a murine model" 15 : R79-, 2013
• 147 Kondratova M, "A multiscale signalling network map of innate immune response in cancer reveals cell heterogeneity signatures" 10 : 4808-, 2019
• 148 Vetsika EK, "A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients" 2014 : 659294-, 2014
• 149 Mecha M, "2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs" 66 : 1447-1463, 2018